Epstein Secrets

l Street Journal. (7/21, Strobel, Subscription Publication, 7.57M) reports that a spokesman for SSCI Acting Chair Marco Rubio said he and Vice Chair Mark Warner had discussed the issue on Tuesday. The spokesman said, "They will continue to work with DNI Ratcliffe and are hopeful that the committee will hold

afety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guideline

gust-11595364921> (7/21, Strobel, Subscription Publication, 7.57M) reports that a spokesman for SSCI Acting Chair Marco Rubio said he and Vice Chair Mark Warner had discussed the issue on Tuesday. The spokesman said, "They will continue to work with DNI Ratcliffe and are hopeful that the committee will hold

2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guidelines.

nn.com/2020/11/23/politics/joe-biden-foreign-policy-national-security-cabinet/index.html> (11/23, Mucha, Krieg, 83.I6M) reports that SSCI Vice Chair Mark Warner (D-VA) "immediately leaned on his Republican colleagues to confirm Haines to lead the intelligence community." Reuters <https://www.reuters.com/art

ting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg

ce background will help the Biden administration hit the ground running in January." CNN (11/23, Mucha, Krieg, 83.16M) reports that SSCI Vice Chair Mark Warner (D-VA) "immediately leaned on his Republican colleagues to confirm Haines to lead the intelligence community." Reuters (11/23, Landay, Hosenball) r

ing an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg (1

ll Street Journal (7/21, Strobel, Subscription Publication, 7.57M) reports that a spokesman for SSCI Acting Chair Marco Rubio said he and Vice Chair Mark Warner had discussed the issue on Tuesday. The spokesman said, "They will continue to work with DNI Ratcliffe and are hopeful that the committee will hold

afety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guideline

e Intelligence Committee on the need to address foreign influence campaigns ahead of the upcoming U.S. elections. According to the article, Senator Mark Warner stressed the importance of combating disinformation funded by Russia, Iran, and China, while the FBI revealed in an affidavit that it had seized 32

, a former FBI agent-in-training. The article mentioned that Seth Markin pleaded guilty last year after prosecutors said he stole information about Merck's then-pending $1.85 billion acquisition of Pandion from his girlfriend at the time, a law firm associate at Covington who was working on the Merck

ll Street Journal (7/21, Strobel, Subscription Publication, 7.57M) reports that a spokesman for SSCI Acting Chair Marco Rubio said he and Vice Chair Mark Warner had discussed the issue on Tuesday. The spokesman said, "They will continue to work with DNI Ratcliffe and are hopeful that the committee will hold

afety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guideline